Wholesale of pharmaceutical and medical goods
CIRCIUS PHARMA AS
Revenue 2024
NOK 13.0m
Operating profit
NOK −30,000
Equity
NOK 2.0m
Incorporated
2021
Share capital
NOK 300,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 13.0m | |
| Total operating costs | 13.0m | |
| Operating profit (EBIT) | −30k | |
| Net financial items | 30k | |
| Profit for the year | 0 |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 7.6m | |
| of which current assets | 6.2m | |
| Equity | 2.0m | |
| Total liabilities | 5.6m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.